Search research articles
Contact Us
Filters
Showing results (11-20 of 164) with videos related to
Page
of 17
Sort By:
Journal of Clinical Pharmacology
|
July 28, 2018
Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients
Xun Bao, Jianmei Wu, Seongho Kim, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2014
Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib
Hao Xiong, Yi-Lin Chiu, Justin L Ricker, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 20, 2016
An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma
Jianmei Wu, Nader Sanai, Xun Bao, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 14, 2012
Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry
Richard Wiegand, Jianmei Wu, Anthony F Shields, et al.
Journal of the American Academy of Dermatology
|
January 17, 2015
Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane
James B Macdonald, Brooke Macdonald, Loren E Golitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2014
Complex disease-, gene-, and drug-drug interactions: impacts of renal function, CYP2D6 phenotype, and OCT2 activity on veliparib pharmacokinetics
Jing Li, Seongho Kim, Xianyi Sha, et al.
Molecular Cancer Therapeutics
|
August 18, 2010
Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone
Qiang Zheng, Xianyi Sha, Jiansheng Liu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 8, 2009
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma
Richard Wiegand, Jianmei Wu, Xianyi Sha, et al.
Journal of the American Academy of Dermatology
|
January 17, 2015
Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways
James B Macdonald, Brooke Macdonald, Loren E Golitz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2026
Advancing Antibody-Drug Conjugates: Current Perspectives and Future Directions
Julian David Etessami, Carmine Valenza, Anthony W Tolcher, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 164) with videos related to
Sort By:
Page
of 17
Journal of Clinical Pharmacology
|
July 28, 2018
Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients
Xun Bao, Jianmei Wu, Seongho Kim, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2014
Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib
Hao Xiong, Yi-Lin Chiu, Justin L Ricker, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 20, 2016
An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma
Jianmei Wu, Nader Sanai, Xun Bao, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 14, 2012
Simultaneous determination of 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl) 5-methyluracil (FMAU) in human plasma by liquid chromatography/tandem mass spectrometry
Richard Wiegand, Jianmei Wu, Anthony F Shields, et al.
Journal of the American Academy of Dermatology
|
January 17, 2015
Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane
James B Macdonald, Brooke Macdonald, Loren E Golitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2014
Complex disease-, gene-, and drug-drug interactions: impacts of renal function, CYP2D6 phenotype, and OCT2 activity on veliparib pharmacokinetics
Jing Li, Seongho Kim, Xianyi Sha, et al.
Molecular Cancer Therapeutics
|
August 18, 2010
Association of human cytochrome P450 1A1 (CYP1A1) and sulfotransferase 1A1 (SULT1A1) polymorphisms with differential metabolism and cytotoxicity of aminoflavone
Qiang Zheng, Xianyi Sha, Jiansheng Liu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 8, 2009
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma
Richard Wiegand, Jianmei Wu, Xianyi Sha, et al.
Journal of the American Academy of Dermatology
|
January 17, 2015
Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intracellular molecular signaling pathways
James B Macdonald, Brooke Macdonald, Loren E Golitz, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 14, 2026
Advancing Antibody-Drug Conjugates: Current Perspectives and Future Directions
Julian David Etessami, Carmine Valenza, Anthony W Tolcher, et al.
Page
of 17